bioAffinity Technologies (BIAFW) Expected to Announce Quarterly Earnings on Monday
by Kim Johansen · The Markets DailybioAffinity Technologies (NASDAQ:BIAFW – Get Free Report) is anticipated to release its resultson Monday, April 6th. Analysts expect bioAffinity Technologies to post earnings of ($2.70) per share and revenue of $1.5530 million for the quarter.
bioAffinity Technologies Stock Performance
bioAffinity Technologies stock opened at $0.36 on Friday. bioAffinity Technologies has a 12 month low of $0.05 and a 12 month high of $0.81. The company’s fifty day simple moving average is $0.30 and its 200-day simple moving average is $0.31.
About bioAffinity Technologies
bioAffinity Technologies, Inc is a clinical-stage medical device company developing an extracorporeal immunoadsorption platform intended to treat Gram-negative sepsis and other severe inflammatory conditions. The company’s technology employs specialized sorbent cartridges designed to selectively bind and remove circulating endotoxins and inflammatory mediators from the bloodstream, with the goal of supporting critical care interventions and improving patient outcomes.
In preclinical studies, bioAffinity’s hemoperfusion devices have demonstrated the ability to capture lipopolysaccharides released by Gram-negative bacteria, leading to reductions in pro-inflammatory cytokines and enhanced survival rates in animal models.